DRG Market Assessment Reports

Report December 14, 2023

Diabetic Retinopathy – Epidemiology – Extrapolated Worldwide Coverage

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key diabetic retinopathy patient populations, covering 171 countries and…

north_east

Report December 14, 2023

Diabetic Retinopathy – Epidemiology – Epidemiology – Diabetic Retinopathy – Mature Markets

Clarivate Epidemiology’s coverage of diabetic retinopathy comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…

north_east

Report December 11, 2023

Allergic Rhinitis – Epidemiology – Mature Markets

Clarivate Epidemiology’s coverage of allergic rhinitis (AR) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…

north_east

Report November 14, 2023

Restless Legs Syndrome – Epidemiology – Mature Markets Data

Clarivate Epidemiology’s coverage of restless legs syndrome (RLS) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…

north_east

Report October 25, 2023

Obstructive Sleep Apnea – Epidemiology – Mature Markets

Clarivate Epidemiology’s coverage of obstructive sleep apnea (OSA) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…

north_east

Report October 13, 2023

Monoclonal Gammopathy of Undetermined Significance – Epidemiology – Mature Markets

Clarivate Epidemiology’s coverage of monoclonal gammopathy of undetermined significance (MGUS) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical…

north_east

Report October 9, 2023